Actualités 11 mai 2021 Le spécialiste vaudois des traitements ophtalmiques Oculis lève $ 57 millions Oculis, société biopharmaceutique spécialisée dans le développement de traitements ophtalmiques innovants, a annoncé la clôture d’un tour de fina...
Actualités 10 mai 2021 Lonza investit CHF 650 millions dans une nouvelle unité de production à Viège Lonza a annoncé un projet d’expansion de ses infrastructures de production cellulaire sur son site de Viège. Les installations seront en place dè...
SWISS Pavilion SWISS BIOTECH Pavilion @ BIO International Convention 2024 03 jun 2024–06 jun 2024 San Diego Estados Unidos
SWISS Pavilion SWISS BIOTECH Pavilion @ BIO International Convention 2024 03 jun 2024–06 jun 2024 San Diego Estados Unidos
News 13 set 2021 Incyte inaugurates its new production plant in Yverdon After establishing its European headquarters in Morges in 2020, American biopharmaceutical group Incyte strengthens its presence in the canton of...
News 10 ago 2021 Women’s health biopharmaceutical company ObsEva receives USD 500 million ObsEva, a Geneva-based biopharmaceutical company dedicated to improving women’s reproductive health, will receive up to USD 500 million for the l...
S-GE Event Tomorrow's Health: Meet the Experts on Space & Health 17 jun 2021 17 jun 2021 Online Suíça
S-GE Event Tomorrow's Health: Meet the Experts on Wearable and Tracking Devices 17 jun 2021 17 jun 2021 Suíça
S-GE Event Tomorrow's Health: Meet the Experts on Patient Data, Empowerment & Blockchain 17 jun 2021 17 jun 2021 Suíça
SWISS Pavilion SWISS BIOTECH Pavilion @ BIO International Convention 2024 03 jun 2024–06 jun 2024 San Diego Estados Unidos